← Browse by Condition
Medical Condition

polyneuropathy inflammatory demyelinating chronic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06290128 Phase 3
Recruiting

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

Enrollment
140 pts
Location
United States, Argen...
Sponsor
Sanofi
View Trial →